These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23325368)

  • 1. The 5-HT1D/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactin.
    de Rezende MG; Garcia-Leal C; Graeff FG; Del-Ben CM
    J Psychopharmacol; 2013 Dec; 27(12):1124-33. PubMed ID: 23325368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive assessment of selective 5-HT(1B/1D)-receptor agonist-induced peripheral vascular effects in humans: comparison of different techniques.
    Vanmolkot FH; de Hoon JN; Barrington P; Peck RW; Dallow NS; Williams PM; McColm J
    Eur J Clin Pharmacol; 2002 Aug; 58(5):303-8. PubMed ID: 12185552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evidence of involvement of nitric oxide pathway in anti-pruritic effects of sumatriptan in chloroquine-induced scratching in mice.
    Haddadi NS; Ostadhadi S; Shakiba S; Afshari K; Rahimi N; Foroutan A; Dehpour AR
    Fundam Clin Pharmacol; 2018 Feb; 32(1):69-76. PubMed ID: 28815720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre afferent input.
    Jeggo RD; Wang Y; Jordan D; Ramage AG
    Br J Pharmacol; 2007 Apr; 150(8):987-95. PubMed ID: 17339842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
    Muñoz-Islas E; Lozano-Cuenca J; González-Hernández A; Ramírez-Rosas MB; Sánchez-López A; Centurión D; Maassenvandenbrink A; Villalón CM
    Eur J Pharmacol; 2009 Aug; 615(1-3):133-8. PubMed ID: 19460365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan.
    Pallanti S; Bernardi S; Allen A; Hollander E
    J Psychopharmacol; 2010 Dec; 24(12):1802-9. PubMed ID: 19825906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the 5-HT1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin.
    Carmichael NM; Charlton MP; Dostrovsky JO
    Pain; 2008 Jan; 134(1-2):97-105. PubMed ID: 17499925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal 5-HT1D receptor function in cluster headache: a neuroendocrine study with sumatriptan.
    Pinessi L; Rainero I; Valfrè W; Lo Giudice R; Ferrero M; Rivoiro C; Arvat E; Gianotti L; Del Rizzo P; Limone P
    Cephalalgia; 2003 Jun; 23(5):354-60. PubMed ID: 12780765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked sexual dimorphism in 5-HT
    Araldi D; Ferrari LF; Green P; Levine JD
    Neuroscience; 2017 Mar; 344():394-405. PubMed ID: 28040566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
    Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
    Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of 5-HT1B/1D receptors in the inflammatory response and oxidative stress in intestinal ischemia/reperfusion in rats.
    Gharishvandi F; Abdollahi A; Shafaroodi H; Mohammad Jafari R; Pasalar P; Dehpour AR
    Eur J Pharmacol; 2020 Sep; 882():173265. PubMed ID: 32574671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery.
    Akin D; Gurdal H
    Br J Pharmacol; 2002 May; 136(2):177-82. PubMed ID: 12010765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I; Case B; Olivier A; Hamel E
    Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation.
    Garcia-Leal C; Del-Ben CM; Leal FM; Graeff FG; Guimarães FS
    J Psychopharmacol; 2010 May; 24(5):683-94. PubMed ID: 19251828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study.
    Amital D; Fostick L; Sasson Y; Kindler S; Amital H; Zohar J
    Eur Neuropsychopharmacol; 2005 May; 15(3):279-82. PubMed ID: 15820416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine effects of sumatriptan.
    Herdman JR; Delva NJ; Hockney RE; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):561-4. PubMed ID: 7862876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
    González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
    Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachyphylaxis to the sumatriptan-induced contractile effect in the human uterine artery but not in human cerebral blood vessels: pharmacological demonstration of the 5-HT(1B) receptor functionality loss.
    Silva SA; Ribeiro CA
    Pharmacology; 2012; 89(1-2):29-36. PubMed ID: 22302025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.
    De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
    Br J Pharmacol; 1999 May; 127(2):405-12. PubMed ID: 10385240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of vasoactivity and platelet aggregation by selective 5-HT receptor antagonism in humans.
    Moerland M; Kemme M; Dijkmans A; Bergougnan L; Burggraaf J
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):575-80. PubMed ID: 21822145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.